Nectero Medical

Nectero Medical

Medical Devices, 515 S 48th St, Tempe, Arizona, 85281, United States, 11-50 Employees

necteromedical.com

  • LinkedIn

phone no Phone Number: 18*********

Who is NECTERO MEDICAL

Nectero Medical is developing a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms (AAA). The Nectero EAST, or Endovascular Aneurysm Stabiliza...

Read More

map
  • 515 S 48th St, Tempe, Arizona, 85281, United States Headquarters: 515 S 48th St, Tempe, Arizona, 85281, United States
  • 2017 Date Founded: 2017
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Medical Devices

checked-icon Does something look wrong? Fix it. | View contact records from NECTERO MEDICAL

Nectero Medical Org Chart and Mapping

Employees

Kim Williams

Vice President of Operations Nectero Medical

Kelvin Ning

SVP, Technology / R&D

Emily Tripoli

Senior Director Product Development

Tor Tjorhom

Research and Development Engineer

Natalie Stevens

Research and Development Engineer

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Nectero Medical

Answer: Nectero Medical's headquarters are located at 515 S 48th St, Tempe, Arizona, 85281, United States

Answer: Nectero Medical's phone number is 18*********

Answer: Nectero Medical's official website is https://necteromedical.com

Answer: Nectero Medical's revenue is $1 Million to $5 Million

Answer: Nectero Medical has 11-50 employees

Answer: Nectero Medical is in Medical Devices

Answer: Nectero Medical contact info: Phone number: 18********* Website: https://necteromedical.com

Answer: Nectero Medical is developing a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms (AAA). The Nectero EAST, or Endovascular Aneurysm Stabilization Treatment System, delivers a compound with a proprietary molecule known as a Stabilizer Agent to the site of the aneurysm. The Stabilizing Agent: * Inhibits further breakdown of the aneurysm by disrupting the aortic degradation process. * Strengthens the vessel wall by cross-linking within the tissue; this wall strengthening lowers the risk of rupture. Our technology allows for earlier intervention in a much safer manner; this can prevent or significantly delay the need for major endovascular (EVAR) or surgical repair. By preventing further degradation of the aneurysm and strengthening the aortic tissue around the aneurysm, many patients can live out their normal life span and never need to face the challenges of EVAR or Surgical repair.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access